News

Ozempic CEO’s Exit From Novo Started With Teams Call Surprise
When Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen dialed into a Teams video call with Chairman Helge ...
Ozempic-Maker CEO Ousted Over Pharma Company’s Rocky Market Downturn
In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...
Novo Nordisk announces CEO transition as share price slips
In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...
Novo Nordisk's CEO is out after the Ozempic maker's stock dropped 50% in a year
CEO Lars Fruergaard Jørgensen will step down after eight years at the helm of the Danish pharmaceutical giant responsible for ...
News Nation on MSN10h
CEO of Novo Nordisk, maker of Ozempic and Wegovy, stepping down
The company pointed to "recent market challenges" and "share price decline" as reasons for Lars Fruergaard Jørgensen's ...
Novo Nordisk CEO Lars Fruergaard Jorgensen to resign as Ozempic faces stiff competition
The CEO of Danish pharmaceutical giant Novo Nordisk, known for its blockbuster weight-loss drug Ozempic, will step down, the ...
Ozempic Maker Novo Nordisk Looks For New Chief, Jørgensen Steps Down From CEO Role
Novo Nordisk CEO steps down after pressure from shareholders. Former CEO to join board as observer. Company remains ...
STAT9h
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, to step down as company seeks a turnaround
Lars Fruergaard Jørgensen is stepping down as Novo Nordisk CEO, with the company citing its stock's recent struggles.
Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...